Effect of nateglinide on the incidence of diabetes and cardiovascular events
Research output: Contribution to journal › Journal article › Research › peer-review
The ability of short-acting insulin secretagogues to reduce the risk of diabetes or cardiovascular events in people with impaired glucose tolerance is unknown.
| Original language | English |
|---|---|
| Journal | Briefings from the New England Journal of Medicine |
| Volume | 362 |
| Issue number | 16 |
| Pages (from-to) | 1463-76 |
| Number of pages | 14 |
| ISSN | 1531-7242 |
| DOIs | |
| Publication status | Published - 22 Apr 2010 |
ID: 34066155